|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM121198804 |
| 003 |
DE-627 |
| 005 |
20231222192543.0 |
| 007 |
tu |
| 008 |
231222s1998 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0404.xml
|
| 035 |
|
|
|a (DE-627)NLM121198804
|
| 035 |
|
|
|a (NLM)12293166
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Oral contraceptives and sickle cell disease
|
| 264 |
|
1 |
|c 1998
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 06.05.1998
|
| 500 |
|
|
|a Date Revised 14.11.2003
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Anemia
|
| 650 |
|
4 |
|a Biology
|
| 650 |
|
4 |
|a Blood Coagulation Effects
|
| 650 |
|
4 |
|a Contraception
|
| 650 |
|
4 |
|a Contraceptive Methods--contraindications
|
| 650 |
|
4 |
|a Contraceptive Methods--side effects
|
| 650 |
|
4 |
|a Diseases
|
| 650 |
|
4 |
|a Embolism
|
| 650 |
|
4 |
|a Family Planning
|
| 650 |
|
4 |
|a Hematological Effects
|
| 650 |
|
4 |
|a Hemic System
|
| 650 |
|
4 |
|a Hereditary Diseases
|
| 650 |
|
4 |
|a Literature Review
|
| 650 |
|
4 |
|a Oral Contraceptives--contraindications
|
| 650 |
|
4 |
|a Oral Contraceptives--side effects
|
| 650 |
|
4 |
|a Physiology
|
| 650 |
|
4 |
|a Risk Factors
|
| 650 |
|
4 |
|a Thromboembolism
|
| 650 |
|
4 |
|a Vascular Diseases
|
| 650 |
|
7 |
|a Contraceptives, Oral
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Contraception Report
|d 1993
|g 8(1998), 6 vom: 17. Jan., Seite 9-11
|w (DE-627)NLM09824602X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:8
|g year:1998
|g number:6
|g day:17
|g month:01
|g pages:9-11
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 8
|j 1998
|e 6
|b 17
|c 01
|h 9-11
|